Bioeconomy Capital

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Tandem PV is a Palo Alto, California-based developer of perovskite and silicon-based photovoltaic cells. Founded in 2016, the company focuses on mechanically stacked perovskite–silicon tandem solar panels that integrate metal-halide perovskite photovoltaics with existing silicon technology to deliver higher efficiency while reducing installed system costs.

Founded in Seattle in 2008, Arzeda specializes in protein design technology. It creates and manufactures proteins and enzymes for pharmaceuticals, industrial chemicals, polymers, and other advanced applications.

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Founded in 2017, Lumen Bioscience is a biotechnology company based in Seattle, Washington. It specializes in developing therapeutic biologics for oral delivery and topical/mucosal applications to treat prevalent diseases. The company utilizes Spirulina, a blue-green algae, as its production platform and offers services in synthetic biology, protein design, immunology, and bioreactor engineering.

RoosterBio specializes in regenerative medicine, offering standardized human mesenchymal stromal cells for research and therapeutic applications. Its platform includes scalable bioprocessing tools, optimized media, and analytical services to streamline product development and accelerate clinical translation.

MicroByre, Inc. is a biotechnology company founded in 2017 and headquartered in Berkeley, California. It specializes in the genetic engineering of non-model micro-species, particularly bacteria that are challenging to manipulate for industrial applications. MicroByre has developed an innovative platform for bacterial domestication, employing an automated characterization pipeline that identifies underutilized bacteria capable of efficiently converting unrefined biomasses into commodity chemicals. This platform leverages a unique dataset to inform minimally precise genetic modifications, enhancing the bacteria's flexibility, yield, and contamination resistance while reducing the need for nutritional additives. By bridging the gap between promising biological research and practical industrial applications, MicroByre positions itself as a valuable partner for various companies seeking to improve their fermentation processes and compete with traditional petrochemical synthesis.

Founded in 2017, Lumen Bioscience is a biotechnology company based in Seattle, Washington. It specializes in developing therapeutic biologics for oral delivery and topical/mucosal applications to treat prevalent diseases. The company utilizes Spirulina, a blue-green algae, as its production platform and offers services in synthetic biology, protein design, immunology, and bioreactor engineering.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Riffyn, Inc. is a company that specializes in developing a cloud-based software solution for experimental process design and data analytics, primarily serving the life sciences, pharmaceutical, food, and chemical industries. Its flagship product, Riffyn Nexus, enables researchers to visually design, measure, analyze, and collaborate on experiments through a user-friendly web interface. This innovative platform enhances the planning and learning cycle of scientific research and development by automatically integrating diverse scientific data in real time, facilitating continuous improvement in R&D processes. By overcoming the limitations of traditional electronic lab notebooks and laboratory information management systems, Riffyn Nexus significantly accelerates development cycles and boosts productivity for advanced scientific organizations. Founded in 2014 and headquartered in Oakland, California, Riffyn provides its software solutions along with implementation, change management, and educational services to clients both domestically and internationally.

Founded in Seattle in 2008, Arzeda specializes in protein design technology. It creates and manufactures proteins and enzymes for pharmaceuticals, industrial chemicals, polymers, and other advanced applications.

Riffyn, Inc. is a company that specializes in developing a cloud-based software solution for experimental process design and data analytics, primarily serving the life sciences, pharmaceutical, food, and chemical industries. Its flagship product, Riffyn Nexus, enables researchers to visually design, measure, analyze, and collaborate on experiments through a user-friendly web interface. This innovative platform enhances the planning and learning cycle of scientific research and development by automatically integrating diverse scientific data in real time, facilitating continuous improvement in R&D processes. By overcoming the limitations of traditional electronic lab notebooks and laboratory information management systems, Riffyn Nexus significantly accelerates development cycles and boosts productivity for advanced scientific organizations. Founded in 2014 and headquartered in Oakland, California, Riffyn provides its software solutions along with implementation, change management, and educational services to clients both domestically and internationally.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Riffyn, Inc. is a company that specializes in developing a cloud-based software solution for experimental process design and data analytics, primarily serving the life sciences, pharmaceutical, food, and chemical industries. Its flagship product, Riffyn Nexus, enables researchers to visually design, measure, analyze, and collaborate on experiments through a user-friendly web interface. This innovative platform enhances the planning and learning cycle of scientific research and development by automatically integrating diverse scientific data in real time, facilitating continuous improvement in R&D processes. By overcoming the limitations of traditional electronic lab notebooks and laboratory information management systems, Riffyn Nexus significantly accelerates development cycles and boosts productivity for advanced scientific organizations. Founded in 2014 and headquartered in Oakland, California, Riffyn provides its software solutions along with implementation, change management, and educational services to clients both domestically and internationally.